Antiepileptic drug which is not considered by the FDA and EMA an indication for treatment of neuropathic pain for lack of definite proof. At latest update, relevant data on its excretion into breast milk were not found. Because of its pharmacokinetics, excretion into breast milk in significant amount is likely. Until more information on this drug is available, other options that are known to be safer are recommended, especially when the baby is a newborn or a premature.